Inventor · disambiguated record
Martin Bohlin
Also filed as: BOHLIN MARTIN · BOHLIN MARTIN H · BOHLIN MARTIN HANS
29 granted patents·8 pending applications·368 citations·filing 1997–2024
97Inventor score
Top patents by PatentIndex Score
37 records- 0197US10975046B2Crystal modifications of odevixibatALBIREO AB·Filed 2019·Granted Apr 13, 2021·22 cites·20 claims
- 0296US11801226B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2020·Granted Oct 31, 2023·11 cites·15 claims
- 0396US11365182B2Crystal modifications of odevixibatALBIREO AB·Filed 2020·Granted Jun 21, 2022·10 cites·18 claims
- 0496US9745276B2Crystal modifications of elobixibatELOBIX AB·Filed 2016·Granted Aug 29, 2017·53 cites·22 claims
- 0596US9701649B2Crystal modifications of elobixibatELOBIX AB·Filed 2016·Granted Jul 11, 2017·53 cites·12 claims
- 0696US9409875B2Crystal modifications of elobixibatELOBIX AB·Filed 2015·Granted Aug 9, 2016·47 cites·6 claims
- 0795US12091394B2Crystal modifications of odevixibatALBIREO AB·Filed 2022·Granted Sep 17, 2024·4 cites·27 claims
- 0895US11802115B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2019·Granted Oct 31, 2023·11 cites·16 claims
- 0994US10183920B2Crystal modifications of elobixibatELOBIX AB·Filed 2015·Granted Jan 22, 2019·24 cites·24 claims
- 1091US11753441B2Solution phase synthesis of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2021·Granted Sep 12, 2023·2 cites·20 claims
- 1190US11078234B2Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2018·Granted Aug 3, 2021·4 cites·21 claims
- 1288US6162816ACrystalline form of the S-enantiomer of omeprazoleASTRAZENECA AB·Filed 1997·Granted Dec 19, 2000·82 cites·17 claims
- 1385US10125165B2Solution phase synthesis and crystallization of beta-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2016·Granted Nov 13, 2018·3 cites·12 claims
- 1485US2025019354A1Crystal Modifications of OdevixibatALBIREO AB·Filed 2024·Application pending·0 cites
- 1582US12508234B2Pharmaceutical formulation of odevixibatALBIREO AB·Filed 2023·Granted Dec 30, 2025·0 cites·20 claims
- 1682US7265124B2Cristalline and amorphous form of a triazolo (4,5-D) pyridimine compoundASTRAZENECA AB·Filed 2005·Granted Sep 4, 2007·13 cites·31 claims
- 1781US7566788B2Crystalline formsASTRAZENECA AB·Filed 2007·Granted Jul 28, 2009·3 cites·3 claims
- 1878US12281179B2Solution phase synthesis of β-turn peptidomimetic cyclic saltsMIMETOGEN PHARMACEUTICALS INC·Filed 2023·Granted Apr 22, 2025·0 cites·1 claims
- 1977US2024130976A1Pharmaceutical Formulation of OdevixibatALBIREO AB·Filed 2023·Application pending·0 cites
- 2076US7273858B2SaltsASTRAZENECA AB·Filed 2003·Granted Sep 25, 2007·12 cites·26 claims
- 2173US6747155B2ProcessASTRAZENECA AB·Filed 2002·Granted Jun 8, 2004·8 cites·7 claims
- 2269US7816545B2Process 054ASTRAZENECA AB·Filed 2008·Granted Oct 19, 2010·1 cites·4 claims
- 2366US9149539B1Crystalline naloxol-PEG conjugateASTRAZENECA AB·Filed 2015·Granted Oct 6, 2015·1 cites·1 claims
- 2466US8563755B2Process for preparing [1S-[1-α, 2-α, 3-β(1S*,2R*) 5-β]]-3-[7-[2-(3,4-difluorophenyl)-cyclopropylamino]-5-(propylthio)-3H-1,2,3-triazolo [4,5-d] pyrimidin-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol and to its intermediatesBOHLIN MARTIN HANS·Filed 2009·Granted Oct 22, 2013·2 cites·2 claims
- 2565US9012469B2Crystalline naloxol-peg conjugateÅSLUND BENGT LEONARD·Filed 2011·Granted Apr 21, 2015·2 cites·14 claims
- 2659US10519120B2Crystal modifications of elobixibatELOBIX AB·Filed 2018·Granted Dec 31, 2019·0 cites·37 claims
- 2756US7763597B2SaltsASTRAZENECA AB·Filed 2007·Granted Jul 27, 2010·0 cites·22 claims
- 2856US2010137304A1Novel crystalline forms of the anti-cancer compound zd1839ASTRAZENECA AB·Filed 2009·Application pending·0 cites
- 2955US2010022610A1New Crystalline FormsBOHLIN MARTIN·Filed 2009·Application pending·0 cites
- 3052US8017785B2Salt forms of (2S)-(4E)-N-methyl-5-[3-(5-isopropoxypyridin)y1]-4-penten 2-amineASTRAZENECA AB·Filed 2007·Granted Sep 13, 2011·0 cites·4 claims
- 3151US10548882B2Camsylate saltASTRAZENECA AB·Filed 2013·Granted Feb 4, 2020·0 cites·7 claims
- 3251US2007293513A1Cristalline and amorphous form of a triazolo (4,5-d) pyridimine compoundASTRAZENECA AB·Filed 2007·Application pending·0 cites
- 3343US2011009647A1Process 054ASTRAZENECA AB·Filed 2010·Application pending·0 cites
- 3442US8124779B2Process for the preparation of esomeprazole non-salt formBOHLIN MARTIN·Filed 2006·Granted Feb 28, 2012·0 cites·7 claims
- 3540US2007099997A1Potassium or sodium salt of (-)-2-{'2-(4-hydroxyphenyl) ethyl!-thio-3-'4-(2-{4-'(methylsulfonyl) oxy! phenoxy}ethyl) phenyl! propanoic acid and their use in medicineAHLQVIST MATTI·Filed 2004·Application pending·0 cites
- 3637US2003181469A1Crystalline and amorphous form of a triazolo(4,5-d)pyrimidine compoundFiled 2001·Application pending·0 cites
- 3729US8658799B2Process for the preparation of crystalline modifications for use in the preparation of esomeperazole sodium saltBOHLIN MARTIN·Filed 2005·Granted Feb 25, 2014·0 cites·7 claims
Join the waitlist — get patent alerts
Get an alert when Martin Bohlin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →